232 related articles for article (PubMed ID: 23874302)
1. The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
Lamon S; Russell AP
Front Physiol; 2013; 4():176. PubMed ID: 23874302
[TBL] [Abstract][Full Text] [Related]
2. EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis.
Lamon S; Zacharewicz E; Stephens AN; Russell AP
Physiol Rep; 2014; 2(3):e00256. PubMed ID: 24760510
[TBL] [Abstract][Full Text] [Related]
3. A novel mechanism of cooperation between c-Kit and erythropoietin receptor. Stem cell factor induces the expression of Stat5 and erythropoietin receptor, resulting in efficient proliferation and survival by erythropoietin.
Kapur R; Zhang L
J Biol Chem; 2001 Jan; 276(2):1099-106. PubMed ID: 11042182
[TBL] [Abstract][Full Text] [Related]
4. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjects.
Christensen B; Lundby C; Jessen N; Nielsen TS; Vestergaard PF; Møller N; Pilegaard H; Pedersen SB; Kopchick JJ; Jørgensen JO
PLoS One; 2012; 7(2):e31857. PubMed ID: 22384088
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin Reduces Insulin Resistance via Regulation of Its Receptor-Mediated Signaling Pathways in
Pan Y; Yang XH; Guo LL; Gu YH; Qiao QY; Jin HM
Int J Biol Sci; 2017; 13(10):1329-1340. PubMed ID: 29104499
[TBL] [Abstract][Full Text] [Related]
8. STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line.
Iwatsuki K; Endo T; Misawa H; Yokouchi M; Matsumoto A; Ohtsubo M; Mori KJ; Yoshimura A
J Biol Chem; 1997 Mar; 272(13):8149-52. PubMed ID: 9079629
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle.
Lundby C; Hellsten Y; Jensen MB; Munch AS; Pilegaard H
J Appl Physiol (1985); 2008 Apr; 104(4):1154-60. PubMed ID: 18218911
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
11. The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization.
Tóthová Z; Šemeláková M; Solárová Z; Tomc J; Debeljak N; Solár P
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299300
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue.
Rotter R; Menshykova M; Winkler T; Matziolis G; Stratos I; Schoen M; Bittorf T; Mittlmeier T; Vollmar B
J Orthop Res; 2008 Dec; 26(12):1618-26. PubMed ID: 18634017
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts.
Ogilvie M; Yu X; Nicolas-Metral V; Pulido SM; Liu C; Ruegg UT; Noguchi CT
J Biol Chem; 2000 Dec; 275(50):39754-61. PubMed ID: 10995753
[TBL] [Abstract][Full Text] [Related]
14. Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors.
Fouquet G; Thongsa-Ad U; Lefevre C; Rousseau A; Tanhuad N; Khongkla E; Saengsawang W; Anurathapan U; Hongeng S; Maciel TT; Hermine O; Bhukhai K
Exp Hematol; 2021 Jul; 99():12-20.e3. PubMed ID: 34077792
[TBL] [Abstract][Full Text] [Related]
15. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
Breig O; Théoleyre-Schaal O; Baklouti F
Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin Does Not Enhance Skeletal Muscle Protein Synthesis Following Exercise in Young and Older Adults.
Lamon S; Zacharewicz E; Arentson-Lantz E; Gatta PA; Ghobrial L; Gerlinger-Romero F; Garnham A; Paddon-Jones D; Russell AP
Front Physiol; 2016; 7():292. PubMed ID: 27458387
[TBL] [Abstract][Full Text] [Related]
17. The Many Facets of Erythropoietin Physiologic and Metabolic Response.
Suresh S; Rajvanshi PK; Noguchi CT
Front Physiol; 2019; 10():1534. PubMed ID: 32038269
[TBL] [Abstract][Full Text] [Related]
18. Induction of functional erythropoietin and erythropoietin receptor gene expression by gamma-aminobutyric acid and piperine in kidney epithelial cells.
Lee YM; Choi JH; Min WK; Han JK; Oh JW
Life Sci; 2018 Dec; 215():207-215. PubMed ID: 30439377
[TBL] [Abstract][Full Text] [Related]
19. The erythropoietin receptor.
Mulcahy L
Semin Oncol; 2001 Apr; 28(2 Suppl 8):19-23. PubMed ID: 11395848
[TBL] [Abstract][Full Text] [Related]
20. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
